The use of methadone among Medicare beneficiaries to treat opioid use disorder increased sharply after the program began covering the drug, with evidence suggesting the change created new treatment rather than displacing use of other medications, according to a new RAND Corporation study.
from Medical Xpress - latest medical and health news stories https://ift.tt/j0WB5Kh
